Journal: International Journal of Molecular Sciences
Article Title: MicroRNA Profiling of PRELI-Modulated Exosomes and Effects on Hepatic Cancer Stem Cells
doi: 10.3390/ijms252413299
Figure Lengend Snippet: Attenuation of drug resistance and cellular viability in SRHs upon inhibition of three miRNAs. ( a ) Results from modeling drug resistance. ( b ) Expression levels of PRELI in SSHs (sorafenib-sensitive hepatocytes) and SRH (sorafenib-resistant hepatocytes). ( c ) Drug resistance in cells transfected with anti-miRNA siRNAs. Fill-patterned bar graphs indicate sensitivity for Sorafenib.CC 50 : cytotoxic concentration 50; NT: non-transfected; T: transfected, Ns: not significant (* p < 0.05, ** p < 0.01).
Article Snippet: Liver cancer stem cells (LCSCs) (sku: 36116-43; Celprogen, Torrance, CA, USA) and normal hepatocytes (NHs) (THLE-3; ATCC, Manassas, VA, USA) were cultured with Human Liver Cancer Stem Cell Media (Celprogen) and BEGM (Bronchial Epithelial Cell Growth Medium) (Lonza, Workingham, UK) using BEGM Bullet Kits (Lonza) at 37 °C, 5% CO 2 .
Techniques: Inhibition, Expressing, Transfection, Concentration Assay